Gloria Matthews is Senior Vice President of Mimedx and President of the Orthopaedic Research Society. Dr. Matthews is a former Senior Director of Orthopaedics at Genzyme and Chief Medical Officer at Histogenics. She received both her DVM (1993) and PhD (2001) from Cornell University and became board certified by the American College of Veterinary Surgeons (1999) following an equine surgery and sports medicine residency at Tufts University. During her 10 year tenure at Genzyme, Dr. Matthews has been involved in clinical and preclinical development and/or post-market support of cell, gene, growth factor and biomaterial based products for orthopaedic and rheumatologic indications, including Carticel®, MACI®, Synvisc®, and Synvisc One®. Areas of active research include cell and molecular biology of osteoarthritis and cartilage repair as well as orthopaedic imaging. Most recently she has directed her research organization toward a focus on the role of bone in development and perpetuation of osteoarthritis pain as well as in the pathophysiology and natural progression of focal chondral defects. The group routinely leverages collaborations with internal and external partners while evaluating external business opportunities in an effort to solve the preclinical and clinical challenges of therapeutic development in this space. Dr. Matthews has received the American College of Veterinary Surgeons Research Publication Award, the Samuel F. Scheidy Memorial Award, administered by the American Veterinary Medical Foundation, a Phi Zeta Research Award, and best research/best poster awards at New England Baptist and Cornell University Research Symposia.Dr. Matthews sits on the Board of Directors for the Orthopaedic Research Society, for which she chairs the Executive Finance Committee as Treasurer. She also serves on the NIH SBIR Scientific Review Group/Grant Review Committee (study section), the Strategic Alliance Committee of the Osteoarthritis Research Society International, the Executive Committee of the fNIH Osteoarthritis Biomarkers Working Group, and the Musculoskeletal Committee of the American Society for Gene and Cell Therapy.